ABSTRACT

The use of adaptive trial designs could greatly improve the efficiency of

drug development; the incorporation of the Bayesian approach is one more

step further to this direction. Bayesian approaches provide a powerful tool

for streamlining sequential learning processes, predicting future results, and

synthesizing evidences across different resources. The resulting outcomes

using Bayesian approaches are easier to interpret and more informative for

decision making.